ClinicalTrials.Veeva

Menu

Clinical Evaluation of the Scopio Cell Morphology Technology (Hemascopio)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Blood Cancer

Treatments

Diagnostic Test: Blood cells classification

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)

Enrollment

300 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope

Exclusion criteria

  • Patients not affected by blood disorders
  • Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope

Trial contacts and locations

1

Loading...

Central trial contact

Elena Rossi, MD; Patrizia Chiusolo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems